KPKalapi Patel

Kalapi Patel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kalapi Patel has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Herzerkrankungen und bewährte Therapiestrategien aus Sicht des Ayurveda

    by Shive Narain Gupta, Kalapi Patel, Martin Mittwede

    Zusammenfassung: Im Ayurveda gehören Herzerkrankungen zu den schwerwiegenden Erkrankungen, weil das Herz als zentrales Lebensorgan angesehen wird, in dem die Lebensenergie und das Bewusstsein beheimatet sind. Verschiedene ätiologische Faktoren provozieren das im Ayurveda beschriebene Prinzip der Doshas und bringen das Prinzip Rasa aus dem Gleichgewicht, was die Qualität der Nährstoffe, die über das Blut zum Herzen transportiert werden, negativ beeinflusst und in der Folge Störungen produziert, die zu einer Herzkrankheit (Hridroga) führen. Zu den bewährten ayurvedischen Behandlungsstrategien bei Hridroga gehören Reinigungstherapien des Körpers, Heilmittel, die auf das Herz wirken und die funktionelle Belastung des Herzens reduzieren, Heilmittel mit einer „auskratzenden“ Wirkung (lekhana) sowie die Änderung des Lebensstils aus ayurvedischer Sicht. Langjährige klinische Erfahrung ist im Ayurveda für ein gutes individuelles Management von Herzkrankheiten notwendig: Anhand von drei Fallbeispielen aus dem P. D. Patel Ayurveda Hospital, Nadiad, Indien, wird die Umsetzung der ayurvedischen Therapie, die in den meisten Fällen eine deutliche Verbesserung bei den Patienten erzielen kann, beschrieben.

  • Open Access

    Effect of Atibalamula and Bhumyamalaki on thirty-three patients of diabetic neuropathy

    by Kalapi Patel, Manish Patel, Sn Gupta

    Diabetic neuropathy is a relatively early and common complication affecting approximately 30% of diabetic patients. According to Ayurvedic principles there is involvement of Vata and Pitta Dosa in diabetic neuropathy. Bhumyamalaki (Phyllanthus niruri) is a plant which shows possibility to pacify these two Dosas. Another plant Atibala (Abutilon indicum) has also Vata pacifying qualities. Present study has been carried out to study the effects of Bhumyamalaki and Atibala on 33 patients of diabetic neuropathy. All the patients have been given Bhumyamalaki Churna 3 g twice a day and decoction of 10 g of Atibala-mula twice a day for 30 days. Neuropathy analyzer machine has been used for exact recording of sensory perception of vibration, cold and hot sensations before and after treatment. Changes in numbness, tingling, burning sensation and pain in lower limbs have also been assessed before and after treatment. Results have been analyzed statistically by applying the 't' test. It can be stated from the results that use of Bhumyamalaki and Atibalamula in the patients of diabetic neuropathy can revert the diminished sensory perception and can reduce the symptoms significantly.


  • Open Access

    Clinical evaluation of Vardhamana Pippali Rasayana in the management of Amavata (Rheumatoid Arthritis)

    by Kalapi Patel, Anamika Soni, Sn Gupta

    Amavata is described as a difficult to cure (Krichhrasadhya) disease in Ayurveda. Pain in joints with swelling is a cardinal feature of this disease. It can be correlated with rheumatoid arthritis described in modern medical science. In conventional medical science, steroids and some nonsteroidal anti-inflammatory drugs are used for its management, but they cause certain dangerous side effects in the patients. Ayurveda promises an excellent therapy for it. The present clinical trial was conducted with the same objective to provide a safe, economical and effective therapy to the patients of Amavata. The present study was conducted in 73 patients having classical symptoms of Amavata. The patients were given Vardhamana Pippali Rasayana for 15 days. Patients with any other acute or chronic systemic illness or infection were excluded from the study. The observations and results obtained were analyzed statistically applying the "t" test. All the patients experienced up to 50% relief from the signs and symptoms of Amavata after the therapy. The drug might have produced its beneficial effects in the patients of Amavata due to its Agnideepana, Amapachana, Vatashamaka and Rasayana effects in the body. A significant decrease in the erythrocyte sedimentation rate in all the patients was also noticed. All the results obtained were highly significant statistically. Thus, it can be implicated that the Vardhamana Pippali Rasayana has a lot of beneficial effects in the patients of Amavata.


  • Open Access

    Effect of Ayurvedic management in 130 patients of diabetic nephropathy

    by Kalapi Patel, Sn Gupta, Namrata Shah

    Diabetic nephropathy is a specific form of renal disease. It is a major cause of renal insufficiency and ultimately of death. The present study has been carried out to prove the efficacy of Ayurvedic drugs in the management of diabetic nephropathy, which can be helpful in reducing the need of dialysis and avoiding or delaying renal transplantation. A total of 130 patients of this disease were treated in IPD (Group A) and OPD (Group B). Ayurvedic formulations including Gokshuradi Guggulu, Bhumyamalaki, Vasa and Shilajatvadi Vati were given to all the patients for 2 months. Group A patients were given special planned food. Results were analyzed statistically using "t" test. In group A patients, highly significant reduction was found in the values of serum creatinine, blood urea and urinary excretion of albumin. Marked improvement was found in the patients' general physical well-being, together with reduction in symptoms, in group A patients. This shows the importance of Pathyapathya in Ayurvedic management of the disease. This management may bring some new hope to the patients of diabetic nephropathy, which usually terminates to chronic renal failure and ultimately to death. Further studies are being carried out in this regard.